Bullock Wealth Management’s AbbVie ABBV Stock Holding History

Bullock Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$311K	Sell	1,239 -136	-10%	-$29.3K	0.14%	138
2026 Q1	$296K	Sell	1,375 -128	-9%	-$28.4K	0.15%	130
2025 Q4	$343K	Buy	1,503 +2	+0.1%	+$456	0.17%	119
2025 Q3	$367K	Sell	1,501 -54	-3%	-$11K	0.18%	110
2025 Q2	$295K	Buy	1,555 +4	+0.3%	+$743	0.16%	115
2025 Q1	$320K	Sell	1,551 -60	-4%	-$11.7K	0.18%	110
2024 Q4	$286K	Sell	1,611 -2,907	-64%	-$534K	0.17%	114
2024 Q3	$890K	Buy	4,518 +63	+1%	+$11.8K	0.54%	42
2024 Q2	$759K	Buy	4,455 +6	+0.1%	+$994	0.5%	48
2024 Q1	$804K	Buy	+4,449	New	+$767K	0.54%	43

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bullock Wealth Management's ABBV Position: Q2 2026 in Review

Bullock Wealth Management reduced its AbbVie (ABBV) stake by 9.9% in Q2 2026, selling an estimated $29.3K and leaving 1,239 shares worth $311K. The position accounts for 0.14% of the portfolio, ranked #138.

Bullock Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $890K in Q3 2024. 4,233 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bullock Wealth Management held 1,239 shares of AbbVie worth $311K as of Q2 2026.
Bullock Wealth Management sold 136 AbbVie shares in Q2 2026, an estimated $29.3K.
AbbVie made up 0.14% of Bullock Wealth Management's portfolio in Q2 2026, its #138 holding.
Bullock Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Bullock Wealth Management's AbbVie position peaked at $890K in Q3 2024.
4,233 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.